Published in Cathet Cardiovasc Diagn on August 01, 1996
Successful endovascular treatment of iatrogenic pseudoaneurysm with a relatively long neck. BMJ Case Rep (2013) 0.87
Pseudoaneurysm of femoral artery after catheterisation: treatment by a mechanical compression device guided by colour Doppler ultrasound. Heart (1998) 0.84
Pseudoaneurysm of the articular branch of the descending genicular artery following double-bundle anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc (2015) 0.76
Novel Technique to Treat Common Femoral Artery Pseudoaneurysm using Angio-Seal Closure Device. Int J Angiol (2014) 0.75
Ultrasound guided treatment of pseudoaneurysm caused by puncture of the common femoral artery. J Ultrasound (2008) 0.75
Surgical management of iatrogenic femoral artery pseudoaneurysms: A 10-year experience. Hippokratia (2013) 0.75
Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med (1992) 5.32
Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med (2001) 5.09
Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation (2000) 3.75
Myopathy as possible side-effect of cyclosporin. Lancet (1989) 3.25
Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med (1991) 2.97
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet (1988) 2.90
Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J Am Coll Cardiol (1999) 2.70
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart (2007) 2.40
Importance of dural ectasia in phenotypic assessment of Marfan's syndrome. Lancet (1999) 2.20
Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol (1992) 2.19
Clinical endpoints in peripheral endovascular revascularization trials: a case for standardized definitions. Eur J Vasc Endovasc Surg (2008) 2.10
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology (2004) 2.09
Recommendations on stent manufacture, implantation and utilization. Study Group of the Working Group on Coronary Circulation. Eur Heart J (1997) 2.05
Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation (2001) 2.02
Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis. Lancet (1978) 2.00
Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation (1986) 1.99
Surgical management of complications after transcatheter closure of an atrial septal defect or patent foramen ovale. J Thorac Cardiovasc Surg (2000) 1.94
Patent foramen ovale and neurosurgery in sitting position: a systematic review. Br J Anaesth (2009) 1.82
Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol (1998) 1.70
HDF2, the second subunit of the Ku homologue from Saccharomyces cerevisiae. J Biol Chem (1996) 1.68
Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation (1997) 1.67
A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J (1999) 1.66
Physiologically assessed coronary collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease. Circulation (1999) 1.66
Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry (2002) 1.63
Plaque sealing by coronary angioplasty. Cathet Cardiovasc Diagn (1995) 1.62
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials. Heart (2005) 1.61
Stenting of superior vena cava and inferior vena cava for symptomatic narrowing after repeated atrial surgery for D-transposition of the great vessels. Br Heart J (1991) 1.59
A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc (2000) 1.58
Prevention of stroke in patients with patent foramen ovale. Int J Stroke (2010) 1.57
Interleukin 1-alpha and tumor necrosis factor-alpha induce oxygen radical production in mesangial cells. Kidney Int (1990) 1.57
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
The acrocallosal syndrome in sisters. Clin Genet (1986) 1.55
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery interventions. Kidney Int (2004) 1.49
Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization. Eur Heart J (2000) 1.49
Aortic dissection as complication of percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn (1992) 1.48
Endomyocardial biopsy in cardiac transplant recipients using the femoral venous approach. Am J Cardiol (1990) 1.46
Indications for intracoronary stent placement: the european view. Working Group on Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.46
Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol (2001) 1.46
Emergency stenting for acute occlusion after coronary balloon angioplasty. Circulation (1988) 1.45
Effects of changes in preload, afterload and inotropic state on ejection and isovolumic phase measures of contractility in the conscious dog. Am J Cardiol (1975) 1.45
Impossibility to cross a stenotic mitral valve with the Inoue balloon: success with a modified technique. Indian Heart J (1994) 1.44
Interventional cardiology in Europe 1994. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1998) 1.44
Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol (2000) 1.43
Acute inflammatory reaction associated with endoluminal bypass grafts. J Endovasc Surg (1997) 1.41
Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach. Circulation (1983) 1.40
Left main coronary angioplasty in a 10-year-old boy with homozygous familial hypercholesterolemia. Cathet Cardiovasc Diagn (1993) 1.40
Coronary interventions in Europe 1992. The Working Group on Coronary Circulation of the European Society of Cardiology. Eur Heart J (1995) 1.39
[Cardiac interventions in Switzerland 1992. PTCA and Fibrinolysis Work Group of the Swiss Cardiology Association]. Schweiz Med Wochenschr (1994) 1.39
[Low-osmolar gadodiamide as alternative contrast agent for diagnostic angiography and angiographic interventions in patients with renal insufficiency]. Rofo (2002) 1.38
[Treatment of fallopian tube pregnancies with prostaglandins]. Geburtshilfe Frauenheilkd (1991) 1.38
Prolonged heparin after uncomplicated coronary interventions: a prospective, randomized trial. Am Heart J (1998) 1.38
[Coronary angioplasty without surgical standby: a prospective study]. G Ital Cardiol (1992) 1.37
Interventional cardiology in Europe 1995. Working Group Coronary Circulation of the European Society of Cardiology. Eur Heart J (1999) 1.36
Pharmacologic and hemodynamic influences on the rate of isovolumic left ventricular relaxation in the normal conscious dog. J Clin Invest (1977) 1.30
The relationship between digital and ocular vasospasm. Graefes Arch Clin Exp Ophthalmol (1988) 1.29
Balloon angioplasty for acute myocardial infarction. Was it buried alive? Circulation (1990) 1.24
Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology (2005) 1.24
Adventitial cystic disease of the popliteal artery: percutaneous US-guided aspiration. Radiology (1997) 1.24
Molecular cloning and partial nucleotide sequence of human papillomavirus type 1a DNA. Virology (1982) 1.22
Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-kappa B. J Biol Chem (1995) 1.21
Should coronary arteries with less than 60% diameter stenosis be treated by angioplasty? Circulation (1983) 1.21
Nature of T-cell macrophage interaction in helper-cell induction in vitro. II. Two stages of T-helper-cell differentiation analyzed in irradiation and allophenic chimeras. J Exp Med (1979) 1.20
Capillary condensation of adsorbates in porous materials. Adv Colloid Interface Sci (2011) 1.17
Synthesis of either Fe- or Mn-superoxide dismutase with an apparently identical protein moiety by an anaerobic bacterium dependent on the metal supplied. J Biol Chem (1982) 1.16
Mural aortic thrombi: An important cause of peripheral embolization. J Vasc Surg (1999) 1.15
Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion. Am J Cardiol (1987) 1.15
Intravascular stenting for stenosis of aortocoronary venous bypass grafts. J Am Coll Cardiol (1989) 1.15
Improvement of left ventricular contraction and relaxation synchronism after recanalization of chronic total coronary occlusion by angioplasty. J Am Coll Cardiol (1987) 1.14
Risk of side branch occlusion during coronary angioplasty. Am J Cardiol (1984) 1.13
[Inadequate treatment compliance, patient information and drug prescription as causes for emergency hospitalization of patients with chronic heart failure]. Schweiz Med Wochenschr (1993) 1.12
Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrob Agents Chemother (1987) 1.11
Sleep need in adolescents: a longitudinal approach. Sleep (1988) 1.11
Intropic effect of tachycardia and poststimulation potentiation in the conscious dog. Am J Physiol (1974) 1.10
Kissing balloon coronary angioplasty. Am J Cardiol (1984) 1.10
Nature of T cell-macrophage interaction in helper cell induction in vitro. I. Evidence for genetic restriction of T cell-macrophage interactions prior to T cell priming. Eur J Immunol (1978) 1.10
Treatment of renovascular hypertension by transluminal renal artery dilatation. Ann Intern Med (1979) 1.10
Aldosterone inhibits uncoupling protein-1, induces insulin resistance, and stimulates proinflammatory adipokines in adipocytes. Horm Metab Res (2005) 1.08
SimpliRED D-dimer assay: comparability of capillary and citrated venous whole blood, between-assay variability, and performance of the test for exclusion of deep vein thrombosis in symptomatic outpatients. Thromb Haemost (1998) 1.08
Foreseeing complications of coronary angioplasty--predicting the unpredictable. Eur Heart J (1999) 1.07
The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses. J Endocrinol (2009) 1.07
Long-term results of successful and failed angioplasty for chronic total coronary arterial occlusion. Am J Cardiol (1990) 1.07
Is genetically related macrophage factor (GRF) a soluble immune response (Ir) gene product? J Immunol (1979) 1.06
Repeat coronary angioplasty. J Am Coll Cardiol (1984) 1.06
Coronary pacing during percutaneous transluminal coronary angioplasty. Circulation (1985) 1.06
Coronary dissection and total coronary occlusion associated with percutaneous transluminal coronary angioplasty: significance of initial angiographic morphology of coronary stenoses. Circulation (1986) 1.06
[Dynamics of return flow from the femoral vein]. Z Kreislaufforsch (1970) 1.05
Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (1986) 1.04
Simultaneous intracoronary velocity- and pressure-derived assessment of adenosine-induced collateral hemodynamics in patients with one- to two-vessel coronary artery disease. J Am Coll Cardiol (1999) 1.04
Novel management strategy for patients with suspected pulmonary embolism. Eur Heart J (2003) 1.04
Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg (2002) 1.03
Therapeutic strategy with total coronary artery occlusions. Am J Cardiol (1997) 1.03
Do vasospasms provoke ocular diseases? Angiology (1990) 1.02
Acute complications of elective coronary angioplasty: a review of 500 consecutive procedures. Br Heart J (1988) 1.02